Medical and procedural treatment of androgenetic alopecia - Where are we?
J Am Acad Dermatol
; 89(2S): S36-S39, 2023 08.
Article
en En
| MEDLINE
| ID: mdl-37591565
Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Finasterida
/
Alopecia
Idioma:
En
Revista:
J Am Acad Dermatol
Año:
2023
Tipo del documento:
Article